UBERON:0000179

Name:	haemolymphatic fluid
Namespace:	FANTOM
Definition:	"Circulating fluid that is part of the hemolymphoid system. Blood, lymph, interstitial fluid or its analogs." []
Synonyms:	"blood or blood analog" RELATED [] "haematological system portion of organism substance" EXACT [OBOL:automatic] "haemopoietic system portion of organism substance" EXACT [OBOL:automatic] "hematopoietic system portion of organism substance" EXACT [OBOL:automatic] "organa haemopoietica portion of organism substance" EXACT [OBOL:automatic] "portion of organism substance of haematological system" EXACT [OBOL:automatic] "portion of organism substance of haemopoietic system" EXACT [OBOL:automatic] "portion of organism substance of hematopoietic system" EXACT [OBOL:automatic] "portion of organism substance of organa haemopoietica" EXACT [OBOL:automatic]
Created by:	cjm
Creation date:	2009-04-08T04:38:19Z

Ontology association<br>Each term has an is_a parent in the Uberon Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to UBERON ontologies.<br><br>link to ontology dataset<br>data

---

Parents

is_a:	UBERON:0006314(bodily fluid)
part_of:	UBERON:0002193(hemolymphoid system)

Children

is a:	UBERON:0000178 (blood)
part of:	CL:0000080 (circulating cell)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples<br>It includes FANTOM5 samples that overlay the Uberon ontology

---

Human (Homo sapiens)

• 10053-101G8 (blood, adult, pool1)
• 10449-106F8 (cord blood derived cell line:COBL-a untreated)
• 10452-106G2 (cord blood derived cell line:COBL-a 24h infection(-C))
• 10453-106G3 (cord blood derived cell line:COBL-a 24h infection)
• 11231-116C7 (Peripheral Blood Mononuclear Cells, donor1)
• 11312-117C7 (Peripheral Blood Mononuclear Cells, donor2)
• 11388-118C2 (Peripheral Blood Mononuclear Cells, donor3)
• 12152-128G1
• 12153-128G2
• 12154-128G3

... further results

Enrichment analysis: top 100 FFCP enriched with this ontology term TOP 100 FANTOM5 Cage Peaks enriched with UBERON:0000179 (haemolymphatic fluid), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data

---

Copy Excel CSV PDF

Search:

P-value	FFCP	Short description

P-value	FFCP	Short description
2.41e-121	FFCP PHASE2:Hg19::chr1:205236716..205236728,+	p13@TMCC2
2.41e-121	FFCP PHASE1:Hg19::chr1:205236716..205236728,+	p13@TMCC2
2.31e-117	FFCP PHASE1:Hg19::chr4:74847473..74847482,-	p@chr4:74847473..74847482, -
2.31e-117	FFCP PHASE2:Hg19::chr14:75444134..75444136,-	p@chr14:75444134..75444136, -
2.31e-117	FFCP PHASE2:Hg19::chr20:54933899..54933911,+	p7@FAM210B
2.31e-117	FFCP PHASE2:Hg19::chr9:38090057..38090092,+	p@chr9:38090057..38090092, +
2.31e-117	FFCP PHASE2:Hg19::chr11:125491251..125491253,-	p@chr11:125491251..125491253, -
2.31e-117	FFCP PHASE1:Hg19::chr9:38090057..38090092,+	p@chr9:38090057..38090092, +
2.31e-117	FFCP PHASE1:Hg19::chr16:31539534..31539538,+	p4@AHSP
2.31e-117	FFCP PHASE2:Hg19::chr2:192318775..192318777,-	p@chr2:192318775..192318777, -
2.31e-117	FFCP PHASE2:Hg19::chr2:127434629..127434640,+	p@chr2:127434629..127434640, +
2.31e-117	FFCP PHASE1:Hg19::chr11:118962235..118962238,+	p5@HMBS
2.31e-117	FFCP PHASE1:Hg19::chr12:111678218..111678221,+	p@chr12:111678218..111678221, +
2.31e-117	FFCP PHASE1:Hg19::chr11:125491251..125491253,-	p@chr11:125491251..125491253, -
2.31e-117	FFCP PHASE1:Hg19::chr16:29810067..29810071,+	p@chr16:29810067..29810071, +
2.31e-117	FFCP PHASE1:Hg19::chr7:44973137..44973140,-	p@chr7:44973137..44973140, -
2.31e-117	FFCP PHASE1:Hg19::chr14:81627978..81627994,-	p@chr14:81627978..81627994, -
2.31e-117	FFCP PHASE1:Hg19::chr14:75444134..75444136,-	p@chr14:75444134..75444136, -
2.31e-117	FFCP PHASE2:Hg19::chr11:118962235..118962238,+	p5@HMBS
2.31e-117	FFCP PHASE1:Hg19::chr20:54933899..54933911,+	p7@FAM210B
2.31e-117	FFCP PHASE2:Hg19::chr12:111678218..111678221,+	p@chr12:111678218..111678221, +
2.31e-117	FFCP PHASE1:Hg19::chr14:65501285..65501318,+	p@chr14:65501285..65501318, +
2.31e-117	FFCP PHASE2:Hg19::chr14:65501285..65501318,+	p@chr14:65501285..65501318, +
2.31e-117	FFCP PHASE2:Hg19::chr16:31539534..31539538,+	p4@AHSP
2.31e-117	FFCP PHASE2:Hg19::chr7:44973137..44973140,-	p@chr7:44973137..44973140, -
2.31e-117	FFCP PHASE2:Hg19::chr11:61044581..61044587,-	p@chr11:61044581..61044587, -
2.31e-117	FFCP PHASE1:Hg19::chr11:61044581..61044587,-	p@chr11:61044581..61044587, -
2.31e-117	FFCP PHASE2:Hg19::chr4:74847473..74847482,-	p@chr4:74847473..74847482, -
2.31e-117	FFCP PHASE1:Hg19::chr2:192318775..192318777,-	p@chr2:192318775..192318777, -
2.31e-117	FFCP PHASE1:Hg19::chr12:829787..829796,-	p@chr12:829787..829796, -
2.31e-117	FFCP PHASE2:Hg19::chr17:42336860..42336865,-	p@chr17:42336860..42336865, -
2.31e-117	FFCP PHASE2:Hg19::chr12:829787..829796,-	p@chr12:829787..829796, -
2.31e-117	FFCP PHASE2:Hg19::chr16:29810067..29810071,+	p@chr16:29810067..29810071, +
2.31e-117	FFCP PHASE1:Hg19::chr2:127434629..127434640,+	p@chr2:127434629..127434640, +
2.31e-117	FFCP PHASE1:Hg19::chr17:42336860..42336865,-	p@chr17:42336860..42336865, -
2.31e-117	FFCP PHASE2:Hg19::chr14:81627978..81627994,-	p@chr14:81627978..81627994, -
8.26e-109	FFCP PHASE2:Hg19::chr6:148938884..148938891,+	p@chr6:148938884..148938891, +
8.26e-109	FFCP PHASE1:Hg19::chr6:148938884..148938891,+	p@chr6:148938884..148938891, +
8.26e-109	FFCP PHASE1:Hg19::chr2:192701558..192701565,-	p@chr2:192701558..192701565, -
8.26e-109	FFCP PHASE2:Hg19::chr2:192701558..192701565,-	p@chr2:192701558..192701565, -
8.23e-106	FFCP PHASE2:Hg19::chr5:95843224..95843228,-	p@chr5:95843224..95843228, -
8.23e-106	FFCP PHASE1:Hg19::chr7:30950369..30950387,+	p@chr7:30950369..30950387, +
8.23e-106	FFCP PHASE1:Hg19::chr6:156352553..156352562,-	p@chr6:156352553..156352562, -
8.23e-106	FFCP PHASE2:Hg19::chr12:30576643..30576644,-	p@chr12:30576643..30576644, -
8.23e-106	FFCP PHASE1:Hg19::chr5:95843224..95843228,-	p@chr5:95843224..95843228, -
8.23e-106	FFCP PHASE2:Hg19::chr6:156352553..156352562,-	p@chr6:156352553..156352562, -
8.23e-106	FFCP PHASE2:Hg19::chr11:76367785..76367794,-	p5@ENST00000531511
8.23e-106	FFCP PHASE1:Hg19::chr11:76367785..76367794,-	p5@ENST00000531511
8.23e-106	FFCP PHASE1:Hg19::chr3:142671745..142671768,-	p@chr3:142671745..142671768, -
8.23e-106	FFCP PHASE1:Hg19::chr17:42335778..42335781,-	p4@SLC4A1
8.23e-106	FFCP PHASE2:Hg19::chr1:154912672..154912683,+	p@chr1:154912672..154912683, +
8.23e-106	FFCP PHASE2:Hg19::chr11:76367970..76367987,-	p2@ENST00000531511
8.23e-106	FFCP PHASE2:Hg19::chr11:5246742..5246755,+	p7@CU675538
8.23e-106	FFCP PHASE1:Hg19::chr10:46076393..46076404,-	p@chr10:46076393..46076404, -
8.23e-106	FFCP PHASE1:Hg19::chr10:8724326..8724327,-	p@chr10:8724326..8724327, -
8.23e-106	FFCP PHASE1:Hg19::chr2:23680232..23680238,-	p@chr2:23680232..23680238, -
8.23e-106	FFCP PHASE2:Hg19::chr2:127434578..127434589,+	p@chr2:127434578..127434589, +
8.23e-106	FFCP PHASE1:Hg19::chr1:154912672..154912683,+	p@chr1:154912672..154912683, +
8.23e-106	FFCP PHASE2:Hg19::chr8:21861540..21861544,+	p@chr8:21861540..21861544, +
8.23e-106	FFCP PHASE2:Hg19::chr10:8724326..8724327,-	p@chr10:8724326..8724327, -
8.23e-106	FFCP PHASE1:Hg19::chr11:5246715..5246726,+	p8@CU675538
8.23e-106	FFCP PHASE2:Hg19::chr3:142671745..142671768,-	p@chr3:142671745..142671768, -
8.23e-106	FFCP PHASE1:Hg19::chr11:76367970..76367987,-	p2@ENST00000531511
8.23e-106	FFCP PHASE2:Hg19::chr12:938316..938322,+	p@chr12:938316..938322, +
8.23e-106	FFCP PHASE2:Hg19::chr10:46076393..46076404,-	p@chr10:46076393..46076404, -
8.23e-106	FFCP PHASE2:Hg19::chr1:161137023..161137027,+	p@chr1:161137023..161137027, +
8.23e-106	FFCP PHASE2:Hg19::chr11:5246715..5246726,+	p8@CU675538
8.23e-106	FFCP PHASE2:Hg19::chr17:42337173..42337177,-	p@chr17:42337173..42337177, -
8.23e-106	FFCP PHASE1:Hg19::chr11:5246742..5246755,+	p7@CU675538
8.23e-106	FFCP PHASE1:Hg19::chr8:21861540..21861544,+	p@chr8:21861540..21861544, +
8.23e-106	FFCP PHASE1:Hg19::chr2:127434578..127434589,+	p@chr2:127434578..127434589, +
8.23e-106	FFCP PHASE1:Hg19::chr1:161137023..161137027,+	p@chr1:161137023..161137027, +
8.23e-106	FFCP PHASE1:Hg19::chr12:30576643..30576644,-	p@chr12:30576643..30576644, -
8.23e-106	FFCP PHASE2:Hg19::chr17:42335778..42335781,-	p4@SLC4A1
8.23e-106	FFCP PHASE2:Hg19::chr2:23680232..23680238,-	p@chr2:23680232..23680238, -
8.23e-106	FFCP PHASE1:Hg19::chr12:938316..938322,+	p@chr12:938316..938322, +
8.23e-106	FFCP PHASE1:Hg19::chr17:42337173..42337177,-	p@chr17:42337173..42337177, -
8.23e-106	FFCP PHASE2:Hg19::chr7:30950369..30950387,+	p@chr7:30950369..30950387, +
9.3e-106	FFCP PHASE2:Hg19::chr7:18520409..18520411,-	p@chr7:18520409..18520411, -
9.3e-106	FFCP PHASE2:Hg19::chr3:39430391..39430424,+	p@chr3:39430391..39430424, +
9.3e-106	FFCP PHASE2:Hg19::chr11:235547..235556,-	p@chr11:235547..235556, -
9.3e-106	FFCP PHASE1:Hg19::chr3:24179318..24179327,+	p@chr3:24179318..24179327, +
9.3e-106	FFCP PHASE2:Hg19::chr3:24179318..24179327,+	p@chr3:24179318..24179327, +
9.3e-106	FFCP PHASE2:Hg19::chr19:17146840..17146843,-	p@chr19:17146840..17146843, -
9.3e-106	FFCP PHASE1:Hg19::chr11:235547..235556,-	p@chr11:235547..235556, -
9.3e-106	FFCP PHASE1:Hg19::chr7:18520409..18520411,-	p@chr7:18520409..18520411, -
9.3e-106	FFCP PHASE1:Hg19::chr3:39430391..39430424,+	p@chr3:39430391..39430424, +
9.3e-106	FFCP PHASE1:Hg19::chr19:17146840..17146843,-	p@chr19:17146840..17146843, -
1.05e-105	FFCP PHASE1:Hg19::chr3:151067996..151068011,-	p@chr3:151067996..151068011, -
1.05e-105	FFCP PHASE1:Hg19::chr13:59545633..59545635,-	p@chr13:59545633..59545635, -
1.05e-105	FFCP PHASE2:Hg19::chr3:151067996..151068011,-	p@chr3:151067996..151068011, -
1.05e-105	FFCP PHASE2:Hg19::chr13:59545633..59545635,-	p@chr13:59545633..59545635, -
1.34e-105	FFCP PHASE2:Hg19::chr4:99783676..99783681,-	p@chr4:99783676..99783681, -
1.34e-105	FFCP PHASE1:Hg19::chr4:99783676..99783681,-	p@chr4:99783676..99783681, -
1.87e-104	FFCP PHASE1:Hg19::chr4:52905409..52905410,-	p@chr4:52905409..52905410, -
1.87e-104	FFCP PHASE1:Hg19::chr8:21927844..21927847,+	p@chr8:21927844..21927847, +
1.87e-104	FFCP PHASE2:Hg19::chr1:206320318..206320322,+	p8@CTSE
1.87e-104	FFCP PHASE2:Hg19::chr4:171855577..171855579,-	p@chr4:171855577..171855579, -
1.87e-104	FFCP PHASE1:Hg19::chr1:206320318..206320322,+	p8@CTSE
1.87e-104	FFCP PHASE1:Hg19::chr1:17803417..17803419,-	p@chr1:17803417..17803419, -

Showing 1 to 100 of 100 entries